Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Am J Clin Oncol. 2020 Jan;43(1):64–68. doi: 10.1097/COC.0000000000000628

Figure 1:

Figure 1:

Survival Curves for Patients Receiving Chemotherapy Alone (Controls) Versus Those Receiving Chemotherapy Plus Anti-VEGF antibodies (AVA). (A) All Patients (B) Non-Hispanic Whites (C) Blacks (D) Hispanic Whites